FDA Matters logo
  • Blog
  • About
  • Media
Rx for FDA: An Agenda for the Commissioner

Rx for FDA: An Agenda for the Commissioner

by Steven Grossman | Apr 15, 2025 | Short Takes and Updates

While FDA’s responsibilities have not changed, its capacity to perform its duties has been significantly reduced. After subtracting approximately 4,500 employees[1] from the agency’s 19,000 employee workforce, it cannot possibly sustain its heavy...
Rx for FDA: An Agenda for the Commissioner

Chesterton’s Fence: The Meaning of Deregulation & Other Thoughts About FDA

by Steven Grossman | Apr 11, 2025 | Short Takes and Updates

Earlier this week, I posted an “FDA-Related Thought of the Day.” According to LinkedIn, it has generated an astounding 29,796 impressions (and counting!). That’s a lot more interest than it garnered when I first posted it a month ago (here). Here is what I said...
Rx for FDA: An Agenda for the Commissioner

The Possible Demise of User Fees: Existential Threats Require Outside-the-Box Thinking

by Steven Grossman | Apr 7, 2025 | Short Takes and Updates

Last Thursday, Alec Gaffney of AgencyIQ declared “…the future of FDA’s user fee programs is in extreme jeopardy” (here). Alec has a well-deserved reputation as one of the best FDA analysts. Alec talks; people listen. For the most part, I agree with him and have...
Rx for FDA: An Agenda for the Commissioner

Rising Concerns About User Fees Addendum to: “The Possible Demise of User Fees: Existential Threats Demand…”

by Steven Grossman | Apr 7, 2025 | Short Takes and Updates

January 24, 2025 column in FDA Matters: https://www.fdamatters.com/fdamatters/keep-calm-and-carry-on-lessons-from-trump-10 Eight years ago, just before President Trump was sworn in for the first time, I expressed my belief in FDA’s ability to survive change. I...
Rx for FDA: An Agenda for the Commissioner

New Administration’s Food Priorities Require Resources, Expertise, and Regulations:Where Will They Come From?

by Steven Grossman | Apr 4, 2025 | Short Takes and Updates

— First appeared in Food Safety News. Reprinted with permission.  — Secretary Kennedy’ announcement came last Thursday: FDA’s contribution to the pending HHS reduction in force (RIF) would be 3,500 employees. That is not quite 20% of the agency’s total workforce....
Rx for FDA: An Agenda for the Commissioner

Random Arbitrary RIF’s Drive the Initial Makary Agenda

by Steven Grossman | Apr 2, 2025 | Short Takes and Updates

— Permission is granted to reprint or recirculate this column, as long as attribution is made to FDA Matters (www.fdamatters.com) and the author.  — Smaller government is possible, albeit not always warranted. In theory, you could RIF 3,500 FDA employees and...
« Older Entries
Next Entries »

Recent Posts

  • Chairman Cassidy: Please Ask Dr. Overton About FDA Decision-Making
  • The FDA’s Century-Long Campaign to Assure Safe Manufacturing (Part 2)
  • The FDA’s Century-Long Campaign to Assure Safe Drug Manufacturing (Part 1)
  • A Marathon, Not a Sprint: The Long Road to Becoming the Next FDA Commissioner
  • Firing Dr. Makary Solves No Problems….BUT Opens the Door for More Orderly Management and Decision-Making

Recent Comments

No comments to show.
FDA Matters logo

 ©2009-2026 FDA Matters | FDA Matters does not report the news….we provide analysis of what’s behind the news.

We sometimes use artificial intelligence in drafting columns, primarily using Claude AI and Microsoft Co-Pilot. We review and verify all findings, interpretations, and final wording.